Medications for Pheochromocytoma

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Pheochromocytoma.

Found 3 Approved Drugs for Pheochromocytoma

Demser

Generic Name
Metyrosine

Demser

Generic Name
Metyrosine
Form: Capsule
Method of administration: Oral
FDA approval date: October 03, 1979
Classification: Catecholamine Synthesis Inhibitor
Metyrosine capsules are indicated in the treatment of patients with pheochromocytoma for: 1. Preoperative preparation of patients for surgery. 2. Management of patients when surgery is contraindicated. 3. Chronic treatment of patients with malignant pheochromocytoma. Metyrosine capsules are not recommended for the control of essential hypertension.

Welireg

Generic Name
Belzutifan

Welireg

Generic Name
Belzutifan
Form: Tablet
Method of administration: Oral
FDA approval date: August 13, 2021
Classification: Hypoxia-inducible Factor Inhibitor
WELIREG is indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. WELIREG is a hypoxia-inducible factor inhibitor indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. ( 1 )

AdreView

Generic Name
Iobenguane I-123

AdreView

Generic Name
Iobenguane I-123
Form: Injection
Method of administration: Intravenous
FDA approval date: September 19, 2008
AdreView is a radiopharmaceutical agent for gamma-scintigraphy indicated for: use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests.
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances